Bhavana Pothuri, MD
Gynecologic Oncology · New York, NYNPI 1659300556
Payments from drug & device makers
Across 1,443 payments — averaging $6866.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.7M
- GSK$1.5M
- Pfizer$1.3M
- Tesaro, Inc.$1.2M
- Eli Lilly$1.2M
- Seagen Inc.$1.1M
- plus $1.8M from 23 others
Across 6 payments — averaging $869.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$5K
- GSK$364
What the payments were for
- Consulting fees$302,38183%
- Speaking & faculty fees$29,6458%
- Travel & lodging$24,3577%
- Food & beverage$9,8473%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 81 | $1,725,392 |
| GSK | 225 | $1,537,631 |
| Pfizer | 107 | $1,275,569 |
| Tesaro, Inc. | 59 | $1,197,877 |
| Eli Lilly | 6 | $1,192,150 |
| Seagen Inc. | 216 | $1,137,893 |
| Clovis Oncology, Inc. | 86 | $583,028 |
| AbbVie | 64 | $309,689 |
| Karyopharm Therapeutics Inc. | 109 | $285,733 |
| Incyte Corporation | 156 | $113,271 |
| Daiichi Sankyo Inc. | 134 | $103,068 |
| Genentech, Inc. | 25 | $101,523 |
| Immunogen, Inc. | 20 | $80,381 |
| Alkermes, Inc. | 4 | $79,269 |
| AstraZeneca | 42 | $52,422 |
| Biontech SE | 23 | $37,826 |
| Eisai Inc. | 27 | $24,913 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $21,943 |
| Genmab U.S., Inc. | 10 | $9,881 |
| Corcept Therapeutics | 9 | $8,944 |
| Astrazeneca UK Limited | 6 | $8,011 |
| Pharmaand GmbH | 6 | $7,473 |
| Regeneron | 5 | $4,709 |
| Beigene USA, Inc. | 2 | $3,900 |
| Novocure GmbH | 3 | $2,802 |
| Gilead | 3 | $2,425 |
| Genentech USA, Inc. | 3 | $214 |
| Novocure Inc. | 3 | $100 |
| Foundation Medicine, Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,908,074 in reported general payments places this provider in the 95th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in New York
- Stephanie BlankNew York$3.3M
- Jason WrightNew York$1M
- Jeannine VillellaNew York$346K
- Nimesh NagarshethNew York$327K
- Leslie BoydNew York$283K
- Konstantin ZakashanskyNew York$266K
- Aliza LeiserNew York$239K
- Mario LeitaoNew York$206K
- Eloise Chapman DavisNew York$204K
- Evelyn CantilloNew York$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.